首页 > 最新文献

The Brown University Psychopharmacology Update最新文献

英文 中文
Lamotrigine and quetiapine interaction 拉莫三嗪与喹硫平的相互作用
Pub Date : 2024-03-29 DOI: 10.1002/pu.31154
Y. W. Francis Lam Pharm.D., FCCP

Widespread use of the atypical antipsychotic quetiapine has resulted in the increased possibility of its interaction with other concurrently administered psychotropic agents. For example, the antiepileptic lamotrigine, commonly prescribed for the management of bipolar disorder, has a potential drug-drug interaction with co-administered quetiapine..

非典型抗精神病药物喹硫平的广泛使用导致其与其他同时服用的精神药物发生相互作用的可能性增加。例如,常用于治疗双相情感障碍的抗癫痫药拉莫三嗪就有可能与同时服用的喹硫平发生药物相互作用。
{"title":"Lamotrigine and quetiapine interaction","authors":"Y. W. Francis Lam Pharm.D., FCCP","doi":"10.1002/pu.31154","DOIUrl":"https://doi.org/10.1002/pu.31154","url":null,"abstract":"<p>Widespread use of the atypical antipsychotic quetiapine has resulted in the increased possibility of its interaction with other concurrently administered psychotropic agents. For example, the antiepileptic lamotrigine, commonly prescribed for the management of bipolar disorder, has a potential drug-drug interaction with co-administered quetiapine..</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140329064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survey finds new users of psychedelics report unusual visual experiences 调查发现迷幻药新使用者报告了不寻常的视觉体验
Pub Date : 2024-03-04 DOI: 10.1002/pu.31148
{"title":"Survey finds new users of psychedelics report unusual visual experiences","authors":"","doi":"10.1002/pu.31148","DOIUrl":"https://doi.org/10.1002/pu.31148","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140031806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benzodiazepine use in pregnancy linked to higher risk of miscarriage 孕期使用苯二氮卓类药物与流产风险升高有关
Pub Date : 2024-03-04 DOI: 10.1002/pu.31140

A population-based study conducted in Taiwan has found that use of benzodiazepines during pregnancy increases risk of miscarriage. This increased risk persisted in analyses that were adjusted for multiple confounding variables, the investigators reported. Results were published online Dec. 27, 2023, in JAMA Psychiatry.

在台湾进行的一项基于人群的研究发现,孕期使用苯二氮卓类药物会增加流产风险。研究人员报告说,在对多种混杂变量进行调整的分析中,这种增加的风险依然存在。研究结果于2023年12月27日在线发表在《美国医学会杂志-精神病学》上。
{"title":"Benzodiazepine use in pregnancy linked to higher risk of miscarriage","authors":"","doi":"10.1002/pu.31140","DOIUrl":"https://doi.org/10.1002/pu.31140","url":null,"abstract":"<p>A population-based study conducted in Taiwan has found that use of benzodiazepines during pregnancy increases risk of miscarriage. This increased risk persisted in analyses that were adjusted for multiple confounding variables, the investigators reported. Results were published online Dec. 27, 2023, in <i>JAMA Psychiatry</i>.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140031907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patients with bipolar II disorder benefit from single dose of psilocybin 双相情感障碍 II 患者从单剂迷幻药中获益
Pub Date : 2024-03-04 DOI: 10.1002/pu.31143

A single 25-mg dose of psilocybin resulted in improvement in depressive symptoms in all 15 participants in an open-label nonrandomized trial enrolling adults with bipolar II disorder. Twelve of the 15 participants met response and remission criteria at the study's 12-week endpoint.

在一项开放标签非随机试验中,15 名患有双相情感障碍 II 的成年人服用单次 25 毫克剂量的迷幻剂后,抑郁症状均有所改善。在为期 12 周的研究终点,15 名参与者中有 12 人达到了反应和缓解标准。
{"title":"Patients with bipolar II disorder benefit from single dose of psilocybin","authors":"","doi":"10.1002/pu.31143","DOIUrl":"https://doi.org/10.1002/pu.31143","url":null,"abstract":"<p>A single 25-mg dose of psilocybin resulted in improvement in depressive symptoms in all 15 participants in an open-label nonrandomized trial enrolling adults with bipolar II disorder. Twelve of the 15 participants met response and remission criteria at the study's 12-week endpoint.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140031910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Your Medication Information 您的用药信息
Pub Date : 2024-03-04 DOI: 10.1002/pu.31151

Rivastigmine tartrate Rivastigmine transdermal system (generic) — Exelon patch (brand)

酒石酸利伐斯的明 Rivastigmine transdermal system (generic) - Exelon patch (brand)
{"title":"Your Medication Information","authors":"","doi":"10.1002/pu.31151","DOIUrl":"https://doi.org/10.1002/pu.31151","url":null,"abstract":"<p><b>Rivastigmine tartrate Rivastigmine transdermal system</b> (generic) — <b>Exelon patch</b> (brand)</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140031797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study finds semaglutide not associated with higher risk of suicidality 研究发现塞马鲁肽与更高的自杀风险无关
Pub Date : 2024-03-04 DOI: 10.1002/pu.31149
{"title":"Study finds semaglutide not associated with higher risk of suicidality","authors":"","doi":"10.1002/pu.31149","DOIUrl":"https://doi.org/10.1002/pu.31149","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140031807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pimavanserin reduced risk of relapse to psychosis in Parkinson's dementia Pimavanserin 可降低帕金森氏痴呆症患者精神病复发的风险
Pub Date : 2024-03-04 DOI: 10.1002/pu.31150
{"title":"Pimavanserin reduced risk of relapse to psychosis in Parkinson's dementia","authors":"","doi":"10.1002/pu.31150","DOIUrl":"https://doi.org/10.1002/pu.31150","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140031808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuropsychiatric effects of glucocorticoids 糖皮质激素的神经精神作用
Pub Date : 2024-03-04 DOI: 10.1002/pu.31141
Y. W. Francis Lam Pharm.D., FCCP

Synthetic glucocorticoids, such as dexamethasone and prednisolone, are commonly used in the treatment of patients with inflammatory conditions and autoimmune disorders. However, the multiple physiological effects that glucocorticoids exert can often result in short- and long-term adverse drug reactions, including neuropsychiatric adverse events. Despite the widespread use of glucocorticoids, the prevalence of neuropsychiatric adverse events with these medications, while believed to be common, has not been rigorously quantified.

合成糖皮质激素,如地塞米松和泼尼松龙,常用于治疗炎症和自身免疫性疾病患者。然而,糖皮质激素所产生的多种生理效应往往会导致短期和长期的药物不良反应,包括神经精神不良反应。尽管糖皮质激素被广泛使用,但这类药物的神经精神不良反应的发生率虽然被认为很常见,但尚未被严格量化。
{"title":"Neuropsychiatric effects of glucocorticoids","authors":"Y. W. Francis Lam Pharm.D., FCCP","doi":"10.1002/pu.31141","DOIUrl":"https://doi.org/10.1002/pu.31141","url":null,"abstract":"<p>Synthetic glucocorticoids, such as dexamethasone and prednisolone, are commonly used in the treatment of patients with inflammatory conditions and autoimmune disorders. However, the multiple physiological effects that glucocorticoids exert can often result in short- and long-term adverse drug reactions, including neuropsychiatric adverse events. Despite the widespread use of glucocorticoids, the prevalence of neuropsychiatric adverse events with these medications, while believed to be common, has not been rigorously quantified.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140031908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discontinuation of benzodiazepines after long-term use increases mortality risk 长期使用苯并二氮杂卓后停药会增加死亡风险
Pub Date : 2024-03-04 DOI: 10.1002/pu.31142

A comparative effectiveness study using a U.S. commercial insurance database has found small increases in risk of mortality and other adverse outcomes when benzodiazepine treatment is discontinued in long-term users. Mortality risk was higher in subgroups of discontinuers both with and without exposure to opioids.

一项使用美国商业保险数据库进行的比较有效性研究发现,长期使用苯并二氮杂卓的患者在停止治疗后,死亡率和其他不良后果的风险会略有增加。无论是否接触过阿片类药物,停药者亚组的死亡率风险都较高。
{"title":"Discontinuation of benzodiazepines after long-term use increases mortality risk","authors":"","doi":"10.1002/pu.31142","DOIUrl":"https://doi.org/10.1002/pu.31142","url":null,"abstract":"<p>A comparative effectiveness study using a U.S. commercial insurance database has found small increases in risk of mortality and other adverse outcomes when benzodiazepine treatment is discontinued in long-term users. Mortality risk was higher in subgroups of discontinuers both with and without exposure to opioids.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140031909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trial of zuranolone for depression finds mild to moderate adverse effects 治疗抑郁症的唑来诺龙试验发现轻度至中度不良反应
Pub Date : 2024-03-04 DOI: 10.1002/pu.31144
{"title":"Trial of zuranolone for depression finds mild to moderate adverse effects","authors":"","doi":"10.1002/pu.31144","DOIUrl":"https://doi.org/10.1002/pu.31144","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140031911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Brown University Psychopharmacology Update
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1